Hypocalcemic disorders
- PMID: 30449546
- DOI: 10.1016/j.beem.2018.05.006
Hypocalcemic disorders
Abstract
Calcium is vital for life, and extracellular calcium concentrations must constantly be maintained within a precise concentration range. Low serum calcium (hypocalcemia) occurs in conjunction with multiple disorders and can be life-threatening if severe. Symptoms of acute hypocalcemia include neuromuscular irritability, tetany, and seizures, which are rapidly resolved with intravenous administration of calcium gluconate. However, disorders that lead to chronic hypocalcemia often have more subtle manifestations. Hypoparathyroidism, characterized by impaired secretion of parathyroid hormone (PTH), a key regulatory hormone for maintaining calcium homeostasis, is a classic cause of chronic hypocalcemia. Disorders that disrupt the metabolism of vitamin D can also lead to chronic hypocalcemia, as vitamin D is responsible for increasing the gut absorption of dietary calcium. Treatment and management options for chronic hypocalcemia vary depending on the underlying disorder. For example, in patients with hypoparathyroidism, calcium and vitamin D supplementation must be carefully titrated to avoid symptoms of hypocalcemia while keeping serum calcium in the low-normal range to minimize hypercalciuria, which can lead to renal dysfunction. Management of chronic hypocalcemia requires knowledge of the factors that influence the complex regulatory axes of calcium homeostasis in a given disorder. This chapter discusses common and rare disorders of hypocalcemia, symptoms and workup, and management options including replacement of PTH in hypoparathyroidism.
Keywords: hypocalcemia; hypoparathyroidism; parathyroid hormone; pseudohypoparathyroidism; vitamin D.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
-
Hypoparathyroidism.Best Pract Res Clin Endocrinol Metab. 2012 Aug;26(4):517-22. doi: 10.1016/j.beem.2012.01.004. Epub 2012 May 31. Best Pract Res Clin Endocrinol Metab. 2012. PMID: 22863393 Review.
-
Pathogenesis and management of hypoparathyroidism and other hypocalcemic disorders.Metabolism. 1975 Jul;24(7):871-98. doi: 10.1016/0026-0495(75)90134-1. Metabolism. 1975. PMID: 166271
-
Management of Hypoparathyroidism: Present and Future.J Clin Endocrinol Metab. 2016 Jun;101(6):2313-24. doi: 10.1210/jc.2015-3910. Epub 2016 Mar 3. J Clin Endocrinol Metab. 2016. PMID: 26938200 Free PMC article. Review.
-
Diagnosis and management of hypocalcemia.Endocrine. 2020 Sep;69(3):485-495. doi: 10.1007/s12020-020-02324-2. Epub 2020 May 4. Endocrine. 2020. PMID: 32367335 Review.
-
Diagnostic and therapeutic aspects of iatrogenic hypoparathyroidism.Tumori. 2003 Sep-Oct;89(5):547-9. doi: 10.1177/030089160308900519. Tumori. 2003. PMID: 14870783 Review.
Cited by
-
Seizures at the onset of aneurysmal SAH: epiphenomenon or valuable predictor?J Neurol. 2021 Feb;268(2):493-501. doi: 10.1007/s00415-020-10173-2. Epub 2020 Aug 27. J Neurol. 2021. PMID: 32852577 Free PMC article.
-
Polymorphisms Contributing to Calcium Status: A Systematic Review.Nutrients. 2021 Jul 21;13(8):2488. doi: 10.3390/nu13082488. Nutrients. 2021. PMID: 34444650 Free PMC article.
-
Romosozumab for managing severe osteoporosis in patients undergoing kidney transplantation: a retrospective case series.JBMR Plus. 2025 Apr 14;9(6):ziaf049. doi: 10.1093/jbmrpl/ziaf049. eCollection 2025 Jun. JBMR Plus. 2025. PMID: 40353207 Free PMC article.
-
Dysmagnesemia Is the Most Common Disturbance of the Calcium-Magnesium-Phosphorous Balance among Older Hospitalized People in Warsaw.Nutrients. 2021 Sep 27;13(10):3395. doi: 10.3390/nu13103395. Nutrients. 2021. PMID: 34684395 Free PMC article.
-
A pilot clinical trial to explore the effects of UV exposure on vitamin D synthesis and inflammatory responses in vitamin D-Deficient adults.Sci Rep. 2025 Jul 2;15(1):22557. doi: 10.1038/s41598-025-09203-8. Sci Rep. 2025. PMID: 40595199 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources